# FDA Inspection 962641 - Windlas Healthcare Private Limited - February 17, 2016

Source: https://www.keypedia.com/records/fda_inspections/windlas-healthcare-private-limited/7a4e2df0-c015-41c8-b4c1-ab23e48d3cfb
Source feed: FDA_Inspections

> FDA Inspection 962641 for Windlas Healthcare Private Limited on February 17, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 962641
- Company Name: Windlas Healthcare Private Limited
- Inspection Date: 2016-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1101210 - 2019-08-30](https://www.keypedia.com/records/fda_inspections/windlas-healthcare-private-limited/a328601d-fb6a-41bc-ba17-bb70c801b498)
- [FDA Inspection 1055378 - 2018-06-01](https://www.keypedia.com/records/fda_inspections/windlas-healthcare-private-limited/2a4f2a4b-c22a-4b88-a902-cbabc5fe252a)
- [FDA Inspection 882841 - 2014-06-13](https://www.keypedia.com/records/fda_inspections/windlas-healthcare-private-limited/13798833-2253-4d96-ad0c-60fe67711dc6)

Company: https://www.keypedia.com/companies/windlas-healthcare-private-limited/1cf912ba-dbe9-4b74-ba3c-a7bc0bd8678f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c